US Stock MarketDetailed Quotes

Adicet Bio (ACET)

Watchlist
  • 7.000
  • +0.650+10.24%
Close Apr 14 15:59 ET
  • 6.950
  • -0.050-0.71%
Post 19:25 ET
67.17MMarket Cap-0.41P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adicet Bio (ACET) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-4.31%122.11M
3.72%31.89M
-15.69%27.95M
-1.39%32.39M
-3.19%29.89M
-3.74%127.62M
-2.61%30.74M
1.08%33.15M
-5.85%32.85M
-7.36%30.87M
Selling and administrative expenses
-18.75%22.99M
-8.30%6.85M
-26.10%5.1M
-42.89%3.97M
1.39%7.07M
6.63%28.29M
9.74%7.47M
4.03%6.9M
6.43%6.95M
6.21%6.97M
-General and administrative expense
-18.75%22.99M
-8.30%6.85M
-26.10%5.1M
-42.89%3.97M
1.39%7.07M
6.63%28.29M
9.74%7.47M
4.03%6.9M
6.43%6.95M
6.21%6.97M
Research and development costs
-0.20%99.13M
7.58%25.04M
-12.95%22.85M
9.74%28.42M
-4.53%22.81M
-6.34%99.32M
-6.00%23.27M
0.33%26.25M
-8.68%25.9M
-10.69%23.9M
Operating profit
4.31%-122.11M
-3.72%-31.89M
15.69%-27.95M
1.39%-32.39M
3.19%-29.89M
3.74%-127.62M
2.61%-30.74M
-1.08%-33.15M
5.85%-32.85M
7.36%-30.87M
Net non-operating interest income expense
-46.40%5.74M
-27.40%1.5M
-57.49%1.16M
-53.38%1.4M
-42.28%1.68M
7.61%10.71M
-5.14%2.07M
8.34%2.73M
14.86%3M
10.16%2.92M
Non-operating interest income
-46.08%5.78M
-26.27%1.52M
-57.07%1.17M
-53.38%1.4M
-42.32%1.68M
7.38%10.71M
-5.10%2.07M
8.33%2.73M
14.68%3M
9.45%2.92M
Non-operating interest expense
800.00%36K
2,300.00%24K
1,100.00%12K
--0
--0
-84.00%4K
--1K
0.00%1K
--0
-89.47%2K
Other net income (expense)
-98.16%-430K
-160.00%-130K
-18.52%-64K
-337.25%-223K
80.33%-12K
98.92%-217K
50.50%-50K
99.72%-54K
58.87%-51K
70.39%-61K
Special income (charges)
----
----
----
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
----
----
----
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
-98.16%-430K
-160.00%-130K
-18.52%-64K
-337.25%-223K
80.33%-12K
62.13%-217K
50.50%-50K
61.97%-54K
58.87%-51K
70.39%-61K
Income before tax
0.27%-116.8M
-6.23%-30.52M
11.88%-26.86M
-4.40%-31.22M
-0.71%-28.21M
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
0.27%-116.8M
-6.23%-30.52M
11.88%-26.86M
-4.40%-31.22M
-0.71%-28.21M
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
Net income continuous Operations
0.27%-116.8M
-6.23%-30.52M
11.88%-26.86M
-4.40%-31.22M
-0.71%-28.21M
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
Minority interest income
Net income attributable to the parent company
0.27%-116.8M
-6.23%-30.52M
11.88%-26.86M
-4.40%-31.22M
-0.71%-28.21M
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
0.27%-116.8M
-6.23%-30.52M
11.88%-26.86M
-4.40%-31.22M
-0.71%-28.21M
17.90%-117.12M
2.58%-28.73M
38.90%-30.48M
7.72%-29.9M
9.28%-28.02M
Basic earnings per share
20.53%-16.95
42.58%-2.94
14.71%-4.64
-3.03%-5.44
11.43%-4.96
59.72%-21.33
52.94%-5.12
70.69%-5.44
56.00%-5.28
51.39%-5.6
Diluted earnings per share
20.53%-16.95
42.58%-2.94
14.71%-4.64
-3.03%-5.44
11.43%-4.96
59.72%-21.33
52.94%-5.12
70.69%-5.44
56.00%-5.28
51.39%-5.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -4.31%122.11M3.72%31.89M-15.69%27.95M-1.39%32.39M-3.19%29.89M-3.74%127.62M-2.61%30.74M1.08%33.15M-5.85%32.85M-7.36%30.87M
Selling and administrative expenses -18.75%22.99M-8.30%6.85M-26.10%5.1M-42.89%3.97M1.39%7.07M6.63%28.29M9.74%7.47M4.03%6.9M6.43%6.95M6.21%6.97M
-General and administrative expense -18.75%22.99M-8.30%6.85M-26.10%5.1M-42.89%3.97M1.39%7.07M6.63%28.29M9.74%7.47M4.03%6.9M6.43%6.95M6.21%6.97M
Research and development costs -0.20%99.13M7.58%25.04M-12.95%22.85M9.74%28.42M-4.53%22.81M-6.34%99.32M-6.00%23.27M0.33%26.25M-8.68%25.9M-10.69%23.9M
Operating profit 4.31%-122.11M-3.72%-31.89M15.69%-27.95M1.39%-32.39M3.19%-29.89M3.74%-127.62M2.61%-30.74M-1.08%-33.15M5.85%-32.85M7.36%-30.87M
Net non-operating interest income expense -46.40%5.74M-27.40%1.5M-57.49%1.16M-53.38%1.4M-42.28%1.68M7.61%10.71M-5.14%2.07M8.34%2.73M14.86%3M10.16%2.92M
Non-operating interest income -46.08%5.78M-26.27%1.52M-57.07%1.17M-53.38%1.4M-42.32%1.68M7.38%10.71M-5.10%2.07M8.33%2.73M14.68%3M9.45%2.92M
Non-operating interest expense 800.00%36K2,300.00%24K1,100.00%12K--0--0-84.00%4K--1K0.00%1K--0-89.47%2K
Other net income (expense) -98.16%-430K-160.00%-130K-18.52%-64K-337.25%-223K80.33%-12K98.92%-217K50.50%-50K99.72%-54K58.87%-51K70.39%-61K
Special income (charges) ----------------------0--0--0--------
-Less:Impairment of capital assets ----------------------0--0--0--------
Other non- operating income (expenses) -98.16%-430K-160.00%-130K-18.52%-64K-337.25%-223K80.33%-12K62.13%-217K50.50%-50K61.97%-54K58.87%-51K70.39%-61K
Income before tax 0.27%-116.8M-6.23%-30.52M11.88%-26.86M-4.40%-31.22M-0.71%-28.21M17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M
Income tax 0000000000
Net income 0.27%-116.8M-6.23%-30.52M11.88%-26.86M-4.40%-31.22M-0.71%-28.21M17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M
Net income continuous Operations 0.27%-116.8M-6.23%-30.52M11.88%-26.86M-4.40%-31.22M-0.71%-28.21M17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M
Minority interest income
Net income attributable to the parent company 0.27%-116.8M-6.23%-30.52M11.88%-26.86M-4.40%-31.22M-0.71%-28.21M17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 0.27%-116.8M-6.23%-30.52M11.88%-26.86M-4.40%-31.22M-0.71%-28.21M17.90%-117.12M2.58%-28.73M38.90%-30.48M7.72%-29.9M9.28%-28.02M
Basic earnings per share 20.53%-16.9542.58%-2.9414.71%-4.64-3.03%-5.4411.43%-4.9659.72%-21.3352.94%-5.1270.69%-5.4456.00%-5.2851.39%-5.6
Diluted earnings per share 20.53%-16.9542.58%-2.9414.71%-4.64-3.03%-5.4411.43%-4.9659.72%-21.3352.94%-5.1270.69%-5.4456.00%-5.2851.39%-5.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -